News
Resources
Blog
Sites
Scott LaGanga serves as Senior Vice President of State Advocacy at PhRMA. He oversees state-based teams responsible for government affairs, public policy and advocacy in all 50 states. With a focus on patients, economic growth and the future of medicine, Scott and his colleagues develop and execute campaigns to ensure that states are well positioned to support biopharmaceutical innovation. Scott completed a master’s of business administration at George Washington University in 2009, with concentrations in international business and management. As a Henry J. Raimondo Fellow at the Eagleton Institute of Politics, Scott received a master’s degree in public affairs and politics from the Edward J. Bloustein School of Planning and Public Policy at Rutgers University. He holds a Bachelor of Arts degree in political science from the University of Maryland, College Park.
Recent Posts
Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US
By Scott LaGanga | July 14, 2022
Our industry continues working to improve patient access and affordability for medicines at the state level. I recently had the opportunity to connect with PhRMA board member Mark Reisenauer,...
Read More
Patients need to pay less for their medicines. States can help.
By Scott LaGanga | January 26, 2022
No one should struggle to afford the medicines they need. Unfortunately, some patients continue to bear more of their medicine costs at the pharmacy counter. Patients with deductibles have seen their...
Read More
West Virginia becomes the first state to lower patient costs by sharing the savings
By Scott LaGanga | April 20, 2021
In a historic moment for patient affordability, last week West Virginia became the first state in the nation to adopt ground-breaking legislation, HB2263, requiring insurers and their PBMs to share...
Read More
The Industry-Labor Partnership: Where Biopharmaceutical Innovation Meets Economic Advancement
By Scott LaGanga | January 28, 2015
As someone who grew up around the biopharmaceutical industry and knows firsthand the impact that it has on local communities, I’m frequently reminded of our members’ far-reaching impact in my role as...
Read More
Real Change for Patients with GI Cancer
By Scott LaGanga | November 17, 2014
“Unless someone like you cares a whole awful lot, nothing is going to get better. It’s not.” Real change and progress, as Dr. Seuss suggests, starts with passionate individuals who want to make a...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
